Titan Biotech Q2 Results

  • BSE: 524717
  • NSE: -
  • ISIN: INE150C01011
  • Sector: Biotechnology & Drugs
BSE
789.724.20 (3.16%)
Volume4.55 K
Updated: Mon 25 Nov, 2024 | 15:28:27
NSE
This stock is not traded on NSE
Today: 767.00
825.00
52-Wk: 375.00
1,017.85

Q2 Results Highlights

  • Total Income
    ₹39.89 Cr.
    (-7.48%)
  • Operating Profit
    ₹6.66 Cr.
    (-7.48%)
  • Profit After Tax
    ₹6.70 Cr.
    (4.62%)
  • Operating Margin
    16.70%
    (-7.63%)
Note: Comparison is on YoY basis

Quarterly - Titan Biotech Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 23QoQ CompSep 23YoY Comp
Total Revenue 39.8934.75-%43.43-%
Selling/ General/ Admin Expenses Total 6.505.42-%5.47-%
Depreciation/ Amortization 1.100.80-%0.86-%
Other Operating Expenses Total 8.126.88-%8.03-%
Total Operating Expense 33.2327.66-%35.57-%
Operating Income 6.667.09-%7.85-%
Net Income Before Taxes 6.727.09-%8.13-%
Net Income 6.706.16-%6.52-%
Diluted Normalized EPS 8.107.47-%7.89-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts